NR1H3 and neoplasm: The trafficking of DCs into the tdLN can also be suppressed by tumor intrinsic alterations, such as increased expression of liver X receptor-α (LXR-α) ligands that would bind to LXR-α on DCs to inhibit CCR7 expression, which is required for DC migration to the tdLN (62, 63).